Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2026)

Inspire Medical Systems has disclosed Long-Term Investments across 8 years of filings, most recently posting $115.9 million for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $115.9 million, up 158.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $115.9 million (up 158.49% YoY), and the FY2025 annual result was $96.3 million, up 35.69% from the prior year.
• Long-Term Investments came in at $115.9 million for Q1 2026 at Inspire Medical Systems, up from $96.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $115.9 million in Q1 2026 to a low of $3.0 million in Q3 2023.
• The 5-year median for Long-Term Investments is $57.9 million (2024), against an average of $59.6 million.
• Across the five-year window, Long-Term Investments surged 4701.96% in 2022 and slipped 22.1% in 2025, its largest moves.
• Inspire Medical Systems' Long-Term Investments stood at $9.8 million in 2022, then slipped by 6.67% to $9.1 million in 2023, then surged by 676.5% to $71.0 million in 2024, then surged by 35.69% to $96.3 million in 2025, then advanced by 20.3% to $115.9 million in 2026.
• The last three Long-Term Investments figures came in at $115.9 million (Q1 2026), $96.3 million (Q4 2025), and $88.4 million (Q3 2025), per Business Quant data.